BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6878374)

  • 1. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cerebral ischemia with Fluosol.
    Peerless SJ; Nakamura R; Rodriguez-Salazar A; Hunter IG
    Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
    Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of perfluorochemicals in the treatment of acute cerebral ischemia.
    Peerless SJ
    Prog Clin Biol Res; 1983; 122():353-62. PubMed ID: 6410404
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI; Iacobacci R; Feiler S
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
    Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of perfluorochemicals on experimental cerebral ischemia].
    Yamashita K; Yamaguchi S; Kobayashi S
    No To Shinkei; 1989 Dec; 41(12):1205-10. PubMed ID: 2627538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
    Tremper KK
    Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effect of fluosol DA and dextran 40 on regional cerebral blood flow, infarction size, and mortality in cats with temporary occlusion of the middle cerebral artery.
    Kolluri S; Heros RC; Hedley-Whyte ET; Vonsattel JP; Miller D; Zervas NT
    Surg Neurol; 1986 Jul; 26(1):3-8. PubMed ID: 2424107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of perftoran on cerebral blood flow in the reperfusion period after global transient brain ischemia].
    Aleksandrin VV; Kozhura VL; Novoderzhkina IS; Moroz VV
    Anesteziol Reanimatol; 2003; (6):50-2. PubMed ID: 14991982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia.
    Kolluri S; Heros RC; Hedley-Whyte ET; Vonsattel JP; Miller D; Zervas NT
    Stroke; 1986; 17(5):976-80. PubMed ID: 3764970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.